Extra daily iron after sleeve gastrectomy to prevent anemia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational cohort study at Kasr Al-Ainy Hospital, Cairo University, compares two routine post-operative supplement strategies in adults undergoing primary laparoscopic sleeve gastrectomy. One cohort receives prophylactic daily elemental iron (Ferrodep 60 mg) in addition to a standard multivitamin, while the other cohort receives only a standard multivitamin (Centrum Silver), with cohort assignment determined by the treating surgical unit's usual practice. Iron indices and anemia status are measured before surgery and at 3 and 6 months post-operatively as part of routine care, and health and quality-of-life information are collected during follow-up visits. The primary outcome is the incidence of iron deficiency anemia within six months after surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 18 to 65 years scheduled to undergo primary laparoscopic sleeve gastrectomy (LSG).
* Capable of understanding and providing written informed consent for participation.
* Able and willing to commit to the 6-month post-operative follow-up schedule at the bariatric clinic.

Exclusion Criteria:

* Prior history of major gastrointestinal surgery (e.g., bowel resection, gastrectomy) that could independently affect iron absorption.
* Pre-existing malabsorptive conditions (e.g., inflammatory bowel disease, celiac disease).
* Diagnosis of other known forms of anemia (e.g., thalassemia, vitamin B12/folate deficiency, anemia of chronic disease) that would confound the diagnosis of iron deficiency anemia (IDA).
* Any condition that, in the investigator's judgment, would interfere with full participation in the study or pose a significant risk.

Where it's running

• Faculty of Medicine Cairo University
  Cairo, Al-Manial Cairo, Egypt Recruiting

Study contacts

• Principal investigator: Aziz — Cairo University
• Study coordinator: Ahmed Eid Aziz, Lecturer
• Email: Ahmed-eid@kasralainy.edu.eg
• Phone: +201127060844

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Vestibular and balance changes before and after sleeve gastrectomy

  This study will see if vestibular (balance) function improves in adults having sleeve gastrectomy for severe obesity by testing them before surgery and at one and six months after surgery.

  Recruiting Istanbul Aydın University · Istanbul, Küçükçekmece · NCT07033221

• A new surgical approach to reduce GERD after weight loss surgery

  This study is testing a new type of weight loss surgery to see if it can help reduce acid reflux in people who have had weight loss surgery.

  Recruiting at 2 sites University of California, Irvine · Orange, California and 1 other locations · NCT06783751

• Iron treatment for children and young adults with Crohn’s disease and iron deficiency anemia

  This study tests how different iron treatment approaches work for kids and young adults with Crohn’s disease and iron deficiency anemia.

  Recruiting Phase 4 Weill Medical College of Cornell University · New York, New York · NCT07925450

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.